Indian Tax-Free Zones Split Drug Makers Over Excise Tax Cuts
This article was originally published in PharmAsia News
Executive Summary
Although the organization representing India's pharmaceutical industry presents a united voice before the government and its budget proposals, individual firms appear to disagree over the latest tax proposal. India's Union Budget proposal contains a provision proposing a 16 percent excise tax on drug makers not located in tax-free zones. The Indian Drug Manufacturers' Association takes the position the tax should be cut in half for small and medium firms not normally found in tax-free zones. A unified industry proposed a reduction of excise taxes for all drug makers, but the Finance Ministry did not respond, so several large drug makers entered tax-free zones. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.